Vivasure Medical has submitted an application seeking premarket approval from the FDA for its PerQseal Elite vascular closure ...

The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

ExoStat Medical has completed an intensive care unit (ICU) observational septic shock study of its MicroTREND System.

Experts at HLTH Europe discussed how to ensure patients have trust in the EHDS to ensure a successful roll-out.

A new podcast series from industry experts Alleima explores the past, present, and future of the medical device industry.